GRADE summary of findings for thrombolysis followed by AC vs AC alone in patients with CSVT
| No. of studies . | Study design . | No. of patients (%) . | Effect . | Certainty . | Importance . | ||
|---|---|---|---|---|---|---|---|
| Thrombolysis followed by AC . | AC alone . | Relative (95% CI) . | Absolute (95% CI) . | ||||
| Mortality (assessed with: all-cause mortality; follow-up: mean, 3.5 years) | |||||||
| 129 | Nonrandomized studies | 0/6 (0.0) | 0/4 (0.0) | Not estimable | Not estimable | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus resolution (complete; follow-up: mean, 3.5 years; assessed with: imaging) | |||||||
| 129 | Nonrandomized studies | 6/6 (100.0) | 3/4 (75.0) | RR, 1.33 (0.72-2.44) | 248 more per 1000 (210 fewer to 1000 more) | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus resolution (follow-up: mean, 3.5 years; assessed with: complete or partial resolution) | |||||||
| 129 | Nonrandomized studies | 6/6 (100.0) | 4/4 (100.0) | RR, 1.00 (0.70-1.43) | 0 fewer per 1000 (300 fewer to 430 more) | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus recurrence (follow-up: mean, 3.5 years) | |||||||
| 129 | Nonrandomized studies | 0/6 (0.0) | 0/4 (0.0) | Not estimable | Not estimable | ⊕○○○ Very low∗,†  | Critical | 
| No. of studies . | Study design . | No. of patients (%) . | Effect . | Certainty . | Importance . | ||
|---|---|---|---|---|---|---|---|
| Thrombolysis followed by AC . | AC alone . | Relative (95% CI) . | Absolute (95% CI) . | ||||
| Mortality (assessed with: all-cause mortality; follow-up: mean, 3.5 years) | |||||||
| 129 | Nonrandomized studies | 0/6 (0.0) | 0/4 (0.0) | Not estimable | Not estimable | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus resolution (complete; follow-up: mean, 3.5 years; assessed with: imaging) | |||||||
| 129 | Nonrandomized studies | 6/6 (100.0) | 3/4 (75.0) | RR, 1.33 (0.72-2.44) | 248 more per 1000 (210 fewer to 1000 more) | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus resolution (follow-up: mean, 3.5 years; assessed with: complete or partial resolution) | |||||||
| 129 | Nonrandomized studies | 6/6 (100.0) | 4/4 (100.0) | RR, 1.00 (0.70-1.43) | 0 fewer per 1000 (300 fewer to 430 more) | ⊕○○○ Very low∗,†  | Critical | 
| Thrombus recurrence (follow-up: mean, 3.5 years) | |||||||
| 129 | Nonrandomized studies | 0/6 (0.0) | 0/4 (0.0) | Not estimable | Not estimable | ⊕○○○ Very low∗,†  | Critical |